IP Library Granted Patent US 8,329,165
Granted Patent B2
US 8,329,165 · App. 12/231,691 · Granted Dec 11, 2012

Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water

Assignee: Intron Biotechnology, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,329,165
App. No.
12/231,691
Granted
Dec 11, 2012
Kind
B2
Abstract

The present invention relates to a composition for the treatment of ballast water containing bacteriophage capable of killing specific target bacteria as an active ingredient in order to eliminate or reduce bacteria including pathogenic bacteria present in ballast water, and a biological treatment method of ballast water.

Claims (2)

1. A biological method for the treatment of ballast water, wherein the method comprises adding a composition that contains a bacteriophage selected from the group consisting of bacteriophage SEP-1 (Accession No, KCTC 11173BP) and bacteriophage EFA-1 (Accession No. KCTC 11289BP) as an active ingredient to the ballast water, wherein the final titer of the bacteriophage is 1×10 1 -1×10 8 pfu/m3.

2. The biological method for the treatment of ballast water according to claim 1 , wherein the composition comprises one or more additional bacteriophages.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2009
From: YOON, SEONGJUN; JUN, SOOYOUN; KANG, SANGHYEON; CHOI, YUNJAIE; SON, JEESOO
To: INTRON BIOTECHNOLOGY, INC.
Reel/Frame 023609/0436 →
Priority Claims (1)
KR 10-2008-0053743 · Jun 9, 2008 · national
Continuity (1)
Related Publication 20090304638A1 · Dec 10, 2009